Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine... Read more
Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine... Read more
News
Feb 23, 2020
BioPortfolio
Alder BioPharmaceuticals: Lundbecks Alder Bio Bet Pays Off With FDA Approval of Migraine Drug
Dec 06, 2019
The Business Journals: Seattle
Alder BioPharmaceuticals: Azelby out as CEO of Alder BioPharmaceuticals following close of $2B acquisition
Oct 25, 2019
The Pharma Letter
Alder BioPharmaceuticals: Lundbeck seeks to move fast with eptinezumab after completing Alder buy
Oct 22, 2019
Cision
Alder BioPharmaceuticals: Lundbeck completes the acquisition of Alder BioPharmaceuticals - a company committed to transforming migraine treatment and prevention
Oct 11, 2019
Cision
Alder BioPharmaceuticals: Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SEC
Oct 10, 2019
GlobeNewswire
Press Release: Alder BioPharmaceuticals : Alder BioPharmaceuticals® Announces First-in-Human Dosing in Phase 1 ALD1910 Study for Preventive Treatment of Migraine
Oct 01, 2019
MarketScreener
Alder BioPharmaceuticals: INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alder BioPharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Sep 27, 2019
Global Legal Chronicle
Alder BioPharmaceuticals: Lundbeck's Acquisition Of Alder BioPharmaceuticals
Sep 22, 2019
The Pharma Letter
Alder BioPharmaceuticals: Look back at pharma news in the week to September 20
Sep 19, 2019
Pharmaceutical Executive
Alder BioPharmaceuticals: Lundbeck Acquires US Migraine Treatment Firm
Alder BioPharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10